| Title |
Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation
|
|---|---|
| Published in |
PLOS ONE, January 2009
|
| DOI | 10.1371/journal.pone.0004173 |
| Pubmed ID | |
| Authors |
Guillaume Mabilleau, Afsie Sabokbar |
| Abstract |
Interleukin-32 (IL-32) is a newly described cytokine produced after stimulation by IL-2 or IL-18 and IFN-gamma. IL-32 has the typical properties of a pro-inflammatory mediator and although its role in rheumatoid arthritis has been recently reported its effect on the osteoclastogenesis process remains unclear. |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 3% |
| India | 1 | 3% |
| Unknown | 38 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 33% |
| Student > Ph. D. Student | 11 | 28% |
| Student > Doctoral Student | 4 | 10% |
| Student > Bachelor | 2 | 5% |
| Student > Master | 2 | 5% |
| Other | 3 | 8% |
| Unknown | 5 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 35% |
| Agricultural and Biological Sciences | 14 | 35% |
| Chemistry | 3 | 8% |
| Immunology and Microbiology | 3 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 5 | 13% |